Market Place
Sourcing Support
Takeda`s oncology execs sharpen focus after restructuring
15 Mar 2025 //
FIERCE BIOTECH
Protagonist, Takeda’s Rusfertide Ph 3 VERIFY Study Positive
03 Mar 2025 //
BUSINESSWIRE
Takeda Pumps $770M Into BridGene Pact to Hit Targets
26 Feb 2025 //
BIOSPACE
EMA approves Takhzyro for HAE patients 12+ year & above
24 Feb 2025 //
PR NEWSWIRE
Takeda Drops Epilepsy Drug, Names New CEO Amid Q3 Earnings
31 Jan 2025 //
BIOSPACE
Takeda Delivers Strong Q3 FY2024 Results
30 Jan 2025 //
BUSINESSWIRE
Julie Will Succeed Christophe Weber as CEO of Takeda in June 2026
30 Jan 2025 //
BUSINESSWIRE
Neurocrine Biosciences Amends Osavampator Collaboration with Takeda
27 Jan 2025 //
PR NEWSWIRE
Takeda discontinues gout med Uloric in US
25 Jan 2025 //
FIERCE PHARMA
Keros, Takeda Partner To Advance Elritercept With Global License
21 Jan 2025 //
GLOBENEWSWIRE
Takeda launches innovation centre, eye to onboard AI-driven talent
20 Jan 2025 //
ECONOMICTIMES
Takeda touts 6 pipeline assets with big sales potential
16 Jan 2025 //
FIERCE PHARMA
Takeda Announces Approval of HYQVIA in Japan
28 Dec 2024 //
PRESS RELEASE
Takeda casts a new line with first DTC ads for HyQvia in CIDP
16 Dec 2024 //
FIERCE PHARMA
Hutchmed to Receive Milestone Payment for FRUZAQLA® Reimbursement
12 Dec 2024 //
GLOBENEWSWIRE
Takeda Highlight Late-Stage Pipeline For Transformative Treatment
12 Dec 2024 //
BUSINESSWIRE
Teva to Divest Teva-Takeda Venture in Japan
05 Dec 2024 //
GLOBENEWSWIRE
Takeda Puts Up to $1.3B for Keros’ Blood Cancer Anemia Drug
04 Dec 2024 //
PRESS RELEASE
Keros Signs Global License Deal with Takeda for Elritercept
03 Dec 2024 //
GLOBENEWSWIRE
Hutchmed Announces Launch by Takeda of FRUZAQLA in Japan
21 Nov 2024 //
GLOBENEWSWIRE
Alloy Partners with Takeda on iPSC-Derived Cell Therapies
20 Nov 2024 //
CONTRACTPHARMA
FDA Issues Form 483 to Takeda Pharmaceutical
15 Nov 2024 //
FDA
Takeda stops phase 2 post-anesthesia trial over slow enrollment
31 Oct 2024 //
FIERCE BIOTECH
HUTCHMED to Receive Milestone Payment for FRUZAQLA® Sales
31 Oct 2024 //
GLOBENEWSWIRE
Takeda Raises FY2024 Outlook After Strong First Half Results
31 Oct 2024 //
BUSINESSWIRE
Takeda And Boston Medical Center Collaborate On Decarbonization
24 Oct 2024 //
BUSINESSWIRE
After prior cuts, Takeda is laying off more staffers in MA
21 Oct 2024 //
FIERCE PHARMA
Takeda axes Huntington’s pact, freeing Wave to pursue partners
18 Oct 2024 //
FIERCE BIOTECH
Joint Venture Established for Incubation of Drug Discovery Programs
08 Oct 2024 //
PR NEWSWIRE
Tempus Expands Takeda Collaboration In Oncology Research
26 Sep 2024 //
BUSINESSWIRE
FDA Issues Form 483 to Takeda Pharmaceutical Company Limited
24 Sep 2024 //
FDA
HUTCHMED Announces Japan Approval For FRUZAQLA By Takeda
23 Sep 2024 //
GLOBENEWSWIRE
Takeda Provides $32M For Global CSR Partnerships
22 Sep 2024 //
BIOSPECTRUM ASIA
Firefly Advances AI-Driven BNA™ Technology in Neuroscience
20 Sep 2024 //
GLOBENEWSWIRE
Takeda Commits $32M To Global CSR Health Partnerships
20 Sep 2024 //
PHARMABIZ
Takeda To Present Additional Data On TAK-861 For Narcolepsy
19 Sep 2024 //
BUSINESSWIRE
Lupin partners with Takeda to commercialise Vonoprazan
18 Sep 2024 //
EXPRESSPHARMA
Takeda Pledges $32M for Global CSR Partnerships Across 93 Countries
18 Sep 2024 //
BUSINESSWIRE
DEA Increases Production Limits on Takeda`s Vyvanse Amid Ongoing Shortages
05 Sep 2024 //
FIERCE PHARMA
Alkem inks licensing pact with Takeda to introduce Vonoprazan in India
03 Sep 2024 //
ECONOMICTIMES
Takeda Hires FleishmanHillard Alum To Head Global Corporate Brand
30 Aug 2024 //
FIERCE PHARMA
Fulcrum Adds Chief Commercial Officer And Chief Regulatory Affairs Officer
19 Aug 2024 //
GLOBENEWSWIRE
Nanoform and Takeda to Collaborate on Plasma-Derived Therapy Formulation
15 Aug 2024 //
PR NEWSWIRE
Ovid Therapeutics Reports Q2 2024 Results And Business Updates
13 Aug 2024 //
GLOBENEWSWIRE
Takeda Receives EU Approval For ADZYNMA® As First Recombinant Therapy For cTTP
08 Aug 2024 //
BUSINESSWIRE
Takeda taps internal leader as head of US oncology business
02 Aug 2024 //
FIERCE BIOTECH
Lundbeck Leaves US Trintellix To Takeda, Focuses On Rexulti
01 Aug 2024 //
FIERCE PHARMA
Takeda`s Entyvio Maintains IBD Market Share Despite Competition
01 Aug 2024 //
FIERCE PHARMA
Takeda takes $140M charge on failed epilepsy drug
01 Aug 2024 //
FIERCE BIOTECH
Takeda Reports Strong Q1 FY2024 Results
31 Jul 2024 //
BUSINESSWIRE
Takeda`s vaccine `Qdenga`, a promising solution for dengue control in India
30 Jul 2024 //
ECONOMICTIMES
BMS axes bispecific months after filing to run phase 3 trial
27 Jul 2024 //
FIERCE BIOTECH
Docs embrace Takeda’s Eohilia, creating competition for Sanofi`s Dupixent
22 Jul 2024 //
FIERCE PHARMA
Dr Reddy`s inks licensing pact with Takeda to sell gastrointestinal drug
20 Jul 2024 //
PRESS RELEASE
Dr. Reddy`s Signs Licensing Deal With Takeda For Vonoprazan
19 Jul 2024 //
PRESS RELEASE
Zydus signs patent licensing agreement with Takeda for `VaultA’ in India
19 Jul 2024 //
INDIANPHARMAPOST
Mankind Pharma signs agreement with Takeda to commercialize Vonoprazan in India
16 Jul 2024 //
INDIANPHARMAPOST
HilleVax stock sink 80% as Norovirus Vaccine flunks phase 2 trial in infants
08 Jul 2024 //
FIERCE BIOTECH
Crosswalk picks up Fabry, Pompe compounds from abandoned Takeda, Codexis collab
02 Jul 2024 //
FIERCE BIOTECH
Takeda to cut another 220 jobs, while Merck KGaA plots its own layoffs
02 Jul 2024 //
FIERCE PHARMA
